Provided by Tiger Fintech (Singapore) Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.88
-0.0039-0.21%
Volume:1.10M
Turnover:2.06M
Market Cap:159.46M
PE:-2.24
High:1.95
Open:1.93
Low:1.86
Close:1.88
52wk High:2.75
52wk Low:0.6254
Shares:84.99M
Float Shares:78.81M
Volume Ratio:0.82
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8376
EPS(LYR):-0.6674
ROE:-780.29%
ROA:-50.33%
PB:-8.99
PE(LYR):-2.81

Loading ...

Jul 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 03, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 23, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 12, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Mar 06, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 06, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 09, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 17, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Dec 03, 2019

Major Issues Report

Current report, item 5.02
Nov 27, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 13, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 13, 2019

Major Issues Report

Current report, items 2.02, 5.02, and 9.01
Oct 15, 2019

Major Issues Report

Current report, item 5.02
Sep 20, 2019

Major Issues Report

Current report, item 5.02